{"entity":{"type":"insider","cik":"0001559515","url":"/insider/0001559515","json_url":"/insider/0001559515.json","name":"Genextra S.p.A.","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":11,"n_filings":7,"first":"2013-10-17","last":"2020-08-17","span_basis":"filed_date"},"name_variants":[{"name":"Genextra S.p.A.","source":"filing","n_filings":7,"first_seen":"2013-10-17","last_seen":"2020-08-17"}],"transactions":[{"id":2937608,"accession":"0001140361-20-018621","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001140361-20-018621","line_url":"/filing/0001140361-20-018621","is_derivative":false,"issuer_cik":"0001270073","issuer_name":"INTERCEPT PHARMACEUTICALS, INC.","issuer_ticker":"ICPT","issuer_name_source":null,"issuer_url":"/issuer/0001270073","owner_cik":"0001559515","owner_name":"Genextra S.p.A.","owner_display_name":"Genextra S.p.A.","owner_url":"/insider/0001559515","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common stock, par value $0.001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1362400.0,"shares_display":"1,362,400","price_per_share":47.06627933000587,"price_display":"47.07","price_state":"stated","total_value":64123098.9592,"total_display":"64,123,098.96","total_whole":"64,123,099","shares_owned_after":4000000.0,"shares_owned_after_display":"4,000,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-08-17","filed_date":"2020-08-17","scope":"insider","n_lines":2},{"id":2937597,"accession":"0001140361-20-018621","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001140361-20-018621","line_url":"/filing/0001140361-20-018621#line-2","is_derivative":false,"issuer_cik":"0001270073","issuer_name":"INTERCEPT PHARMACEUTICALS, INC.","issuer_ticker":"ICPT","issuer_name_source":null,"issuer_url":"/issuer/0001270073","owner_cik":"0001559515","owner_name":"Genextra S.p.A.","owner_display_name":"Genextra S.p.A.","owner_url":"/insider/0001559515","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common stock, par value $0.001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":54600.0,"shares_display":"54,600","price_per_share":50.5515,"price_display":"50.55","price_state":"stated","total_value":2760111.9,"total_display":"2,760,111.90","total_whole":"2,760,112","shares_owned_after":5362400.0,"shares_owned_after_display":"5,362,400","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-08-14","filed_date":"2020-08-17","scope":"insider"},{"id":2937591,"accession":"0001140361-20-018621","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001140361-20-018621","line_url":"/filing/0001140361-20-018621#line-1","is_derivative":false,"issuer_cik":"0001270073","issuer_name":"INTERCEPT PHARMACEUTICALS, INC.","issuer_ticker":"ICPT","issuer_name_source":null,"issuer_url":"/issuer/0001270073","owner_cik":"0001559515","owner_name":"Genextra S.p.A.","owner_display_name":"Genextra S.p.A.","owner_url":"/insider/0001559515","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common stock, par value $0.001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":83000.0,"shares_display":"83,000","price_per_share":52.5958,"price_display":"52.60","price_state":"stated","total_value":4365451.4,"total_display":"4,365,451.40","total_whole":"4,365,451","shares_owned_after":5417000.0,"shares_owned_after_display":"5,417,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-08-13","filed_date":"2020-08-17","scope":"insider"},{"id":2498700,"accession":"0001559515-20-000001","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001559515-20-000001","line_url":"/filing/0001559515-20-000001#line-1","is_derivative":false,"issuer_cik":"0001270073","issuer_name":"INTERCEPT PHARMACEUTICALS, INC.","issuer_ticker":"ICPT","issuer_name_source":null,"issuer_url":"/issuer/0001270073","owner_cik":"0001559515","owner_name":"Genextra S.p.A.","owner_display_name":"Genextra S.p.A.","owner_url":"/insider/0001559515","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common stock, par value $0.001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":595578.0,"shares_display":"595,578","price_per_share":84.6,"price_display":"84.60","price_state":"stated","total_value":50385898.8,"total_display":"50,385,898.80","total_whole":"50,385,899","shares_owned_after":5500000.0,"shares_owned_after_display":"5,500,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-05-13","filed_date":"2020-05-15","scope":"insider"},{"id":6250240,"accession":"0000897204-18-000042","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000897204-18-000042","line_url":"/filing/0000897204-18-000042#line-1","is_derivative":false,"issuer_cik":"0001270073","issuer_name":"INTERCEPT PHARMACEUTICALS, INC.","issuer_ticker":"ICPT","issuer_name_source":null,"issuer_url":"/issuer/0001270073","owner_cik":"0001559515","owner_name":"Genextra S.p.A.","owner_display_name":"Genextra S.p.A.","owner_url":"/insider/0001559515","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common stock, par value $0.001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":750000.0,"shares_display":"750,000","price_per_share":105.07,"price_display":"105.07","price_state":"stated","total_value":78802500.0,"total_display":"78,802,500.00","total_whole":"78,802,500","shares_owned_after":6095578.0,"shares_owned_after_display":"6,095,578","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-11-29","filed_date":"2018-12-03","scope":"insider"},{"id":6380788,"accession":"0000897204-18-000028","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000897204-18-000028","line_url":"/filing/0000897204-18-000028#line-1","is_derivative":false,"issuer_cik":"0001270073","issuer_name":"INTERCEPT PHARMACEUTICALS INC","issuer_ticker":"ICPT","issuer_name_source":null,"issuer_url":"/issuer/0001270073","owner_cik":"0001559515","owner_name":"Genextra S.p.A.","owner_display_name":"Genextra S.p.A.","owner_url":"/insider/0001559515","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common stock, par value $0.001 per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":390625.0,"shares_display":"390,625","price_per_share":64.0,"price_display":"64.00","price_state":"stated","total_value":25000000.0,"total_display":"25,000,000.00","total_whole":"25,000,000","shares_owned_after":6845578.0,"shares_owned_after_display":"6,845,578","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-04-09","filed_date":"2018-04-09","scope":"insider"},{"id":6530388,"accession":"0001144204-14-022268","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001144204-14-022268","line_url":"/filing/0001144204-14-022268#line-2","is_derivative":false,"issuer_cik":"0001270073","issuer_name":"INTERCEPT PHARMACEUTICALS INC","issuer_ticker":"ICPT","issuer_name_source":null,"issuer_url":"/issuer/0001270073","owner_cik":"0001559515","owner_name":"Genextra S.p.A.","owner_display_name":"Genextra S.p.A.","owner_url":"/insider/0001559515","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":30623.0,"shares_display":"30,623","price_per_share":293.91,"price_display":"293.91","price_state":"stated","total_value":9000405.93,"total_display":"9,000,405.93","total_whole":"9,000,406","shares_owned_after":6454953.0,"shares_owned_after_display":"6,454,953","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-04-10","filed_date":"2014-04-11","scope":"insider"},{"id":6530384,"accession":"0001144204-14-022268","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001144204-14-022268","line_url":"/filing/0001144204-14-022268#line-1","is_derivative":false,"issuer_cik":"0001270073","issuer_name":"INTERCEPT PHARMACEUTICALS INC","issuer_ticker":"ICPT","issuer_name_source":null,"issuer_url":"/issuer/0001270073","owner_cik":"0001559515","owner_name":"Genextra S.p.A.","owner_display_name":"Genextra S.p.A.","owner_url":"/insider/0001559515","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":318695.0,"shares_display":"318,695","price_per_share":320.0,"price_display":"320.00","price_state":"stated","total_value":101982400.0,"total_display":"101,982,400.00","total_whole":"101,982,400","shares_owned_after":5620195.0,"shares_owned_after_display":"5,620,195","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-04-09","filed_date":"2014-04-11","scope":"insider"},{"id":5351527,"accession":"0001144204-13-056566","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001144204-13-056566","line_url":"/filing/0001144204-13-056566#line-1","is_derivative":false,"issuer_cik":"0001270073","issuer_name":"INTERCEPT PHARMACEUTICALS INC","issuer_ticker":"ICPT","issuer_name_source":null,"issuer_url":"/issuer/0001270073","owner_cik":"0001559515","owner_name":"Genextra S.p.A.","owner_display_name":"Genextra S.p.A.","owner_url":"/insider/0001559515","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, par value $0.001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":124912.0,"shares_display":"124,912","price_per_share":62.5,"price_display":"62.50","price_state":"stated","total_value":7807000.0,"total_display":"7,807,000.00","total_whole":"7,807,000","shares_owned_after":5938890.0,"shares_owned_after_display":"5,938,890","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-10-21","filed_date":"2013-10-23","scope":"insider"},{"id":5159849,"accession":"0001144204-13-055678","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001144204-13-055678","line_url":"/filing/0001144204-13-055678#line-1","is_derivative":false,"issuer_cik":"0001270073","issuer_name":"INTERCEPT PHARMACEUTICALS INC","issuer_ticker":"ICPT","issuer_name_source":null,"issuer_url":"/issuer/0001270073","owner_cik":"0001559515","owner_name":"Genextra S.p.A.","owner_display_name":"Genextra S.p.A.","owner_url":"/insider/0001559515","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, par value $0.001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1123415.0,"shares_display":"1,123,415","price_per_share":62.5,"price_display":"62.50","price_state":"stated","total_value":70213437.5,"total_display":"70,213,437.50","total_whole":"70,213,438","shares_owned_after":6063802.0,"shares_owned_after_display":"6,063,802","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-10-15","filed_date":"2013-10-17","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":11,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":1,"open_market":true},{"code":"S","label":"Open-market sale","n":10,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":11},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001270073","name":"INTERCEPT PHARMACEUTICALS, INC.","url":"/issuer/0001270073","role":"Ten percent owner","n_filings":7,"first_seen":"2013-10-17","last_seen":"2020-08-17"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001559515","retrieved_at":"2026-08-23T14:23:17+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}